CCA
GH icon

Catalyst Capital Advisors’s Guardant Health GH Stock Holding History

Catalyst Capital Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-211
Closed -$13K – 344
2019
Q3 		$13K Buy
211
+45
+27% +$3.96K ﹤0.01% 325
2019
Q2 		$14K Buy
166
+75
+82% +$5.73K ﹤0.01% 289
2019
Q1 		$7K Sell
91
-15
-14% -$832 ﹤0.01% 325
2018
Q4 		$4K Buy
+106
New +$3.9K ﹤0.01% 381

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VS
VK Services Menlo Park, California $1.01M AUM 157.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $31.9B AUM 28.45% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Catalyst Capital Advisors's GH Position: Q4 2019 in Review

Catalyst Capital Advisors sold out of Guardant Health (GH) in Q4 2019, closing a stake of 211 shares — an estimated $13K sold.

Catalyst Capital Advisors first reported a position in GH in Q4 2018 and held it in 4 quarters. The position peaked at $14K in Q2 2019. 268 funds tracked by Wall St. Rank hold GH as of Q4 2019.

  • Catalyst Capital Advisors reported no remaining Guardant Health position as of Q4 2019 after selling out during the quarter.
  • Catalyst Capital Advisors sold 211 Guardant Health shares in Q4 2019, an estimated $13K.
  • Catalyst Capital Advisors first reported a position in Guardant Health in Q4 2018 and held it in 4 quarters.
  • Catalyst Capital Advisors's Guardant Health position peaked at $14K in Q2 2019.
  • 268 funds tracked by Wall St. Rank held Guardant Health as of Q4 2019.

Based on Catalyst Capital Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.